Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats
- PMID: 11523311
- DOI: 10.1358/mf.2001.23.3.627945
Effects of lisinopril on streptozotocin-induced diabetic neuropathy in rats
Abstract
Streptozotocin (STZ)-induced diabetic neuropathy in rats was monitored by measuring the motor nerve conduction velocity (MNCV) and histopathology of the tibial nerve. Pretreatment with lisinopril (2 mg/kg p.o., 5 days prior to STZ and continued for 10 weeks) significantly (p < 0.01) prevented deterioration of MNCV as compared to STZ-diabetic animals. Nerve sections from the lisinopril pretreated group revealed less structural damage as compared to STZ-diabetic rats. However lisinopril had no effect on blood sugar, i.e., it did not alter the diabetic state. It is concluded that lisinopril prevents the development of experimental diabetic neuropathy in STZ-induced diabetic rats.
Similar articles
-
Effect of lacidipine pre-treatment on diabetic neuropathy in rats.Arch Physiol Biochem. 2011 Feb;117(1):12-7. doi: 10.3109/13813455.2010.525241. Epub 2010 Nov 22. Arch Physiol Biochem. 2011. PMID: 21091185
-
Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.Exp Neurol. 1992 Feb;115(2):292-6. doi: 10.1016/0014-4886(92)90064-w. Exp Neurol. 1992. PMID: 1735473
-
ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.Acta Diabetol. 1993;30(1):21-4. doi: 10.1007/BF00572869. Acta Diabetol. 1993. PMID: 8392402
-
Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats.Diabetologia. 1992 Jan;35(1):12-8. doi: 10.1007/BF00400846. Diabetologia. 1992. PMID: 1371757
-
Alternatives to the Streptozotocin-Diabetic Rodent.Int Rev Neurobiol. 2016;127:89-112. doi: 10.1016/bs.irn.2016.03.002. Epub 2016 Mar 28. Int Rev Neurobiol. 2016. PMID: 27133146 Free PMC article. Review.
Cited by
-
Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?Curr Diabetes Rev. 2022;18(5):e040521193121. doi: 10.2174/1573399817666210504101609. Curr Diabetes Rev. 2022. PMID: 33949936 Free PMC article. Review.
-
Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.Neuropharmacology. 2017 Apr;116:122-131. doi: 10.1016/j.neuropharm.2016.12.022. Epub 2016 Dec 23. Neuropharmacology. 2017. PMID: 28025096 Free PMC article.
-
Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.Rev Diabet Stud. 2015 Spring-Summer;12(1-2):13-28. doi: 10.1900/RDS.2015.12.13. Epub 2015 Aug 10. Rev Diabet Stud. 2015. PMID: 26676659 Free PMC article. Review.
-
Current understanding of the link between angiotensin-converting enzyme and pain perception.Drug Discov Today. 2024 Sep;29(9):104089. doi: 10.1016/j.drudis.2024.104089. Epub 2024 Jul 6. Drug Discov Today. 2024. PMID: 38977123 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical